#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Acute myeloid leukaemia Tuberous sclerosis complex Erythema Alagille syndrome Philadelphia positive chronic myeloid leukaemia Hypocalcaemia Encephalitis autoimmune Warm autoimmune haemolytic anaemia Cardiac amyloidosis Oesophageal atresia Cystic fibrosis respiratory infection suppression Systemic sclerosis pulmonary Extra-osseous Ewing's sarcoma recurrent Chronic myelomonocytic leukaemia Cystic fibrosis gastrointestinal disease More trials…

    Learn about Rare Diseases

    Hairy cell leukaemia – Trials in Disease Hereditary hypophosphataemic rickets – Diagnostics Glycogen storage disease type I – Treatment Congenital generalised lipodystrophy – Basic Information Haemophilia A without inhibitors – Treatment Factor VIII deficiency – Basic Information Primary biliary cholangitis – Life with Disease Pituitary-dependent Cushing’s syndrome – Trials in Disease Mantle cell lymphoma stage IV Synovial sarcoma – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Cannabidiol Glepaglutide Cobolimab Asciminib Hydrochloride Tezepelumab Pregabalin Canakinumab SODIUM DIHYDROGEN PHOSPHATE Inavolisib Ketoprofen [14C]ZIPALERTINIB Tigulixostat Vutrisiran Mycophenolic Acid Ianalumab Lbl-007 Metformin Sodium Acetate Trihydrate Gad20-209-Fsp-A1 Isotretinoin More therapies…

    Learn about Your Condition

    Ewing's sarcoma recurrent Osteogenesis imperfecta Laryngeal leukoplakia Hypertension Bile duct adenocarcinoma Altered state of consciousness Childhood asthma Clinically isolated syndrome Food allergy Transient ischaemic attack Retinal vein occlusion Skin cancer Pneumococcal infection Retroperitoneal cancer Carcinoid tumour pulmonary More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. University Of Debrecen

University Of Debrecen

Msebql Zbchzghn Ksjay 2iu Danuhvqck 4ggop Hwxnpes

Want to learn more about this study or check if you can participate? Contact us.

  • Study on the Effectiveness and Safety of ANX007 Injections for Patients with Geographic Atrophy from Age-Related Macular Degeneration

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Dry age-related macular degeneration
    Investigated Drugs:
    • ANX007
    Austria Czechia France Germany Hungary Italy +3

  • Study of Eftilagimod Alfa with Pembrolizumab and Chemotherapy for Patients with Advanced Non-Small Cell Lung Cancer

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Eftilagimod Alfa
    • Carboplatin
    • Cisplatin
    Austria Belgium Bulgaria Croatia Germany Greece +9

  • Study on Long-term Safety and Effectiveness of Zasocitinib for Patients with Moderate-to-Severe Plaque Psoriasis

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Zasocitinib
    Bulgaria Czechia France Germany Hungary Italy +3

  • Study on the Effects of Brepocitinib and Prednisone for Adults with Active Non-Infectious Uveitis

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Chorioretinitis
    • Uveitis
    Investigated Drugs:
    • Brepocitinib Tosilate
    • Prednisone
    Austria Belgium Czechia Germany Greece Hungary +3

  • Comparison of two doses of cabozantinib (60 mg vs 140 mg) in patients with progressive metastatic medullary thyroid cancer

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Medullary thyroid cancer
    Investigated Drugs:
    • Cabozantinib
    Croatia Hungary Poland Romania

  • Study of TL-895 and Navtemadlin for Patients with Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

    Not recruiting

    2 1 1
    Investigated Diseases:
    • B-cell small lymphocytic lymphoma
    • Chronic lymphocytic leukaemia
    Investigated Drugs:
    • 1-4-{[6-Amino-5-(4-Phenoxy-Phenyl)-Pyrimidin-4-Ylamino]-Methyl}-4-Fluoro-Piperidin-1-Yl)-Propenone
    Hungary Poland

  • Study on the Effects of Abiprubart for Patients with Sjögren’s Disease

    Not recruiting

    2 1
    Investigated Diseases:
    • Sjogren’s syndrome
    Investigated Drugs:
    • Kpl-404
    Czechia France Germany Hungary Poland Spain

  • Study of Tozorakimab effectiveness and safety in former smokers with Chronic Obstructive Pulmonary Disease (COPD) who experience disease flare-ups

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Chronic obstructive pulmonary disease
    Investigated Drugs:
    • Tozorakimab
    • Salbutamol
    Belgium Bulgaria Denmark France Germany Greece +6

  • Study on the Safety and Effectiveness of APG777 for Patients with Moderate-to-Severe Atopic Dermatitis

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Dermatitis atopic
    Investigated Drugs:
    • Apg777
    Czechia France Germany Hungary Poland Spain

  • Study of Atropine Sulfate eye drops (0.

    Not recruiting

    3 1
    Investigated Diseases:
    • Myopia
    Investigated Drugs:
    • Atropine Sulfate
    Hungary Ireland Poland Slovakia Spain
Previous Page
1 … 27 28 29 30 31 … 52
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!